Find out if you’re a candidate for Semaglutide or Tirzepatide for weight loss!
Semaglutide and Tirzepatide can help regulate blood sugar by lowering insulin resistance. It also assists with reducing hunger, improving metabolism, and resulting in a gradual and safe reduction in weight. Semaglutide and Tirzepatide are GLP agonists, with numerous benefits. These medications have been shown to reduce the risk of heart attack, lower the risk of depression, and even reduce the risk of certain types of cancer. If you are overweight and think you might benefit from weight loss treatment, call Gemini Urgent Care for more information at 281-461-1111.
Mounjaro and Zepbound are two brand names for Tirzepatide. Wegovy and Ozempic are two brand names for Semaglutide.
Semaglutide, traditionally a medication prescribed for type 2 diabetes, has been found to have off-label uses in aiding weight loss. In 2020, the FDA approved Semaglutide under brand name Wegovy for use in weight management. Studies have shown that patients who took Semaglutide had statistically significant beneficial changes in body weight and fat mass. Tirzepatide, also known as Mounjaro, soon followed suit with approval under the name Zepbound.
Here’s how they work:
At Gemini Urgent Care, we obtain Semaglutide from a compounding pharmacy, and gradually increase the dosage to minimize side effects while maximzing benefit. Every four weeks, the dose is slightly increased. After four months, you reach a maximum level that can be maintained.
Semaglutide can significantly reduce weight, especially when combined with a low-calorie diet and regular exercise.
